This week's reads kept asking the same thing from different angles. Is the AI build-out still an equity story, or has it quietly become a credit story? One piece assumes the bust and works out what follows. Another says the timing depends on maturity dates. The third is a reminder of what...

This week's reads kept making the same accusation from different angles: we're counting the wrong population. Forbes lists stand in for American wealth. Frontier labs stand in for AI demand. Western decoupling from China is told as a one-way story. Each piece argues that the visible headcount hides...

This week's reads kept circling one question. When someone builds a new wrapper that gives ordinary investors access to something, what else rides along in the package? One piece shows what happened when leveraged single-stock products met a strong story. A regulator shipped a cousin of that...

This week's reads made two claims that sound like they contradict each other. One says AI compute will stay short of demand through 2028. Another says Opus-class work now costs about a tenth of what it did. Both can be true at once. When they are, the margin moves to new owners, and these pieces...

This week's reads contradicted each other in a useful way. The October jobs data says the AI build-out is now carrying a visible share of US manufacturing employment. Election night says voters in a lot of places would like less of it. Meanwhile, the biggest AI company to file for an IPO is asking...

Across this week's reads, positions that look like separate bets kept turning out to be the same bet. AI lab equity, hyperscaler credit, emerging-market earnings, and even "global" bond yields all trace back to one or two underlying drivers. The pieces disagree about whether that is a mania or a...

Every aggregate I read this week said "fine." The S&P 500 is up double digits, GDP held up through a tariff shock, and AI hasn't dented employment. But each time I opened up the aggregate, the same beam was holding it up: the AI buildout. So the question for this issue is whether we're looking at...

Two smart readers looked at this expansion this week and came away with different confidence levels. One measured how narrow U.S. growth has become and called it fragile. The other finances that growth for a living and puts the odds of it continuing at 85%. Between them sits a bond market charging...

This week's reads share one question: when a headline number improves, did the risk shrink or just change address? Tariff inflation fades while prices stay high. A bank's capital ratio rises while its parent's doesn't. The "riskless" anchor in valuation is now an adjusted estimate. I kept finding...

Anthropic filed its S-1 this week, and everything else I read seemed to be arguing about it. I came away with one question: what exactly is the buyer of this stock paying for? Damodaran says it's a single revenue assumption. Noah Smith says it's a moat that may not exist. Azeem Azhar says the value...